Correlation Between Bank Polska and Ryvu Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bank Polska and Ryvu Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank Polska and Ryvu Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank Polska Kasa and Ryvu Therapeutics SA, you can compare the effects of market volatilities on Bank Polska and Ryvu Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank Polska with a short position of Ryvu Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank Polska and Ryvu Therapeutics.

Diversification Opportunities for Bank Polska and Ryvu Therapeutics

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between Bank and Ryvu is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Bank Polska Kasa and Ryvu Therapeutics SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ryvu Therapeutics and Bank Polska is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank Polska Kasa are associated (or correlated) with Ryvu Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ryvu Therapeutics has no effect on the direction of Bank Polska i.e., Bank Polska and Ryvu Therapeutics go up and down completely randomly.

Pair Corralation between Bank Polska and Ryvu Therapeutics

Assuming the 90 days trading horizon Bank Polska Kasa is expected to under-perform the Ryvu Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Bank Polska Kasa is 3.41 times less risky than Ryvu Therapeutics. The stock trades about -0.04 of its potential returns per unit of risk. The Ryvu Therapeutics SA is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  5,000  in Ryvu Therapeutics SA on August 27, 2024 and sell it today you would earn a total of  1,000.00  from holding Ryvu Therapeutics SA or generate 20.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Bank Polska Kasa  vs.  Ryvu Therapeutics SA

 Performance 
       Timeline  
Bank Polska Kasa 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bank Polska Kasa has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.
Ryvu Therapeutics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Ryvu Therapeutics SA are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Ryvu Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Bank Polska and Ryvu Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bank Polska and Ryvu Therapeutics

The main advantage of trading using opposite Bank Polska and Ryvu Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank Polska position performs unexpectedly, Ryvu Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ryvu Therapeutics will offset losses from the drop in Ryvu Therapeutics' long position.
The idea behind Bank Polska Kasa and Ryvu Therapeutics SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account